AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and ...

Expanded eligibility for advanced ischemic stroke therapies and the first detailed recommendations pediatric stroke care are ...

The American Heart Association and American Stroke Association have issued an updated guideline for the diagnosis and treatment of acute ischemic stroke.The new guideline, published in Stroke, ...

Phagenesis, a commercial-stage company with a first-of-its-kind neuromodulation system to treat patients experiencing ...

News and commentary from the world of neurology and neuroscience ...

Stroke prevention saves money and lives. Will you take action?

Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.

Overlooked or underestimated risk factors may warrant more consideration in stroke prevention and epidemiology, according to ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...